As of May 31, Verici Dx held a cash position of $1.04 million, which included a $750,000 milestone payment from Thermo Fisher (NYSE: TMO) related to its Pre Transplant Risk Assessment test. This ...

NEW YORK – Danaher subsidiary Cepheid announced Wednesday that its Xpert HIV-1 Viral Load XC assay has received a medical device license from Health Canada. The next-generation extended coverage test ...

Background Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic liver disease. The performance of non-invasive tests has been evaluated against histological assessment of ...

NEW YORK – Qiagen and Foresight Diagnostics will codevelop a next-generation sequencing-based minimal residual disease companion diagnostic kit for lymphomas and other malignancies, the firms ...